You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中恆集團(600252.SH):擬出資2.4億元參設合夥企業 以投資醫藥健康領域優質項目
格隆匯 06-17 16:53

格隆匯6月17日丨中恆集團(600252.SH)公佈,為更好的貫徹公司產融投協同發展戰略,加大資本運作力度,實現內生式與外延式發展,公司擬通過與國海創新資本設立深圳市國海中恆醫藥健康創業投資合夥企業(有限合夥)(暫定名,以市場監管部門審核為準)來實現高端產業資源和優勢專家團隊的整合,投資醫藥健康領域的優質項目,為公司佈局新治療領域、實現產業轉型升級以及提升公司市值水平提供助力。

該基金規模擬定為3億元,其中,公司出資2.4億元,佔比80%;國海創新資本出資6,000萬元,佔比20%。

公司和國海證券股份有限公司(“國海證券”)的控股股東均為廣投集團,國海創新資本為國海證券的全資子公司,公司與國海創新資本設立基金屬於共同投資行為,該次交易構成關聯交易,不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。

2021年6月16日,公司召開第九屆董事會第二十六次會議、第九屆監事會第十四次會議分別審議通過了《廣西梧州中恆集團股份有限公司關於擬投資設立深圳市國海中恆醫藥健康創業投資合夥企業暨關聯交易的議案》,同意公司參與該次投資。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account